Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunization Against COVID-19”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04896957
What this trial is testing

Perceptions and Representations of Vaccination Against COVID-19

Who this might be right for
COVID-19 Acute Respiratory Distress Syndrome
Centre Hospitalier Intercommunal Creteil 14
Testing effectiveness (Phase 2)Study completedNCT04437875
What this trial is testing

An Open Study of the Safety, Tolerability and Immunogenicity of "Gam-COVID-Vac Lyo" Vaccine Against COVID-19

Who this might be right for
Preventive Immunization COVID-19
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 38
Large-scale testing (Phase 3)Study completedNCT04327206
What this trial is testing

BCG Vaccination to Protect Healthcare Workers Against COVID-19

Who this might be right for
Coronavirus Disease 2019 (COVID-19)Respiratory IllnessCorona Virus Infection+1 more
Murdoch Childrens Research Institute 6,828
Testing effectiveness (Phase 2)UnknownNCT05238649
What this trial is testing

Immunogenicity and Safety of Sequential Immunization of Recombinant SARS-CoV-2 Fusion Protein Vaccine

Who this might be right for
COVID-19 Pandemic
Livzon Pharmaceutical Group Inc. 150
Not applicableUnknownNCT04715438
What this trial is testing

Vaccination Against COVID-19 in Cancer

Who this might be right for
Cancer
University Medical Center Groningen 791
Not applicableUnknownNCT05618548
What this trial is testing

Vaccination Against COVID-19 in Pregnant and Lactating Women in Belgium

Who this might be right for
Covid19
Universiteit Antwerpen 110
Early research (Phase 1)UnknownNCT05171946
What this trial is testing

Phase-I Study to Evaluate the Safety and Immunogenicity of a Prophylactic pDNA Vaccine Candidate Against COVID-19 in Healthy Adults

Who this might be right for
SafetyVaccine ReactionVaccine Adverse Reaction+1 more
Iman Almansour 30
Testing effectiveness (Phase 2)Study completedNCT05142553
What this trial is testing

Immunogenicity and Safety of a Booster Vaccination With a Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Healthy Adults Volunteers Fully Vaccinated Followed by an Extension Period to Study a Fourth Dose Administration.

Who this might be right for
COVID-19SARS-CoV-2 Acute Respiratory Disease
Hipra Scientific, S.L.U 887
Not applicableStudy completedNCT05311904
What this trial is testing

Efficacy and Safety of Vaccination Against COVID-19 in Neuromuscular Patients

Who this might be right for
Neuromuscular Diseases
University Hospital, Bordeaux 1,388
Not applicableStudy completedNCT04871776
What this trial is testing

Use of Construal Level Theory to Inform Messaging to Increase Vaccination Against COVID-19

Who this might be right for
Covid19Vaccine Refusal
Brigham and Women's Hospital 3,671
Large-scale testing (Phase 3)Study completedNCT05069649
What this trial is testing

Efficacy and Safety of Ergoferon for COVID-19 Prevention During Vaccination Against SARS-CoV-2

Who this might be right for
Immunization Against COVID-19
Materia Medica Holding 1,057
Testing effectiveness (Phase 2)UnknownNCT04988048
What this trial is testing

Collaborative Study to Evaluate Heterologous Vaccination Against Covid-19 in Argentina

Who this might be right for
COVID-19 VACCINECovid19
Ministry of Public Health, Argentina 1,760
Not applicableStudy completedNCT04979871
What this trial is testing

SARS-CoV-2 Antibodies and Virus Neutralisation in a Cohort Vaccinted Against COVID-19

Who this might be right for
Vaccine Reaction
University of Zurich 50
Large-scale testing (Phase 3)Study completedNCT06181292
What this trial is testing

Safety and Immunogenicity of a Booster Vaccination With an Adapted Vaccine

Who this might be right for
SARS-CoV2 Infection
Hipra Scientific, S.L.U 913
Testing effectiveness (Phase 2)Study completedNCT04979949
What this trial is testing

Booster Vaccination Against COVID-19

Who this might be right for
COVID-19Sars-CoV-2 Infection
Health Institutes of Turkey 222
Not applicableStudy completedNCT04844489
What this trial is testing

Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised People

Who this might be right for
Autoimmune or Autoinflammatory DiseasesHIVMultiple Sclerosis+2 more
Assistance Publique - Hôpitaux de Paris 377
Large-scale testing (Phase 3)Study completedNCT05715944
What this trial is testing

Incidence of COVID-19 Following Vaccination in Botswana Against SARS CoV 2

Who this might be right for
COVID-19
Botswana Harvard AIDS Institute Partnership 10,888
Early research (Phase 1)Study completedNCT05743335
What this trial is testing

Assess the Safety and Immunogenicity of JCXH-221, an MRNA-based Broadly Protective COVID-19 Vaccine

Who this might be right for
COVID-19Infectious Disease
Immorna Biotherapeutics, Inc. 73
Post-approval studies (Phase 4)Study completedNCT05057182
What this trial is testing

Third Dose of mRNA Vaccination to Boost COVID-19 Immunity (mBoost Study)

Who this might be right for
COVID 19 Vaccine
The University of Hong Kong 300
Large-scale testing (Phase 3)Study completedNCT05096832
What this trial is testing

Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Study

Who this might be right for
COVID-19 Pandemic
Livzon Pharmaceutical Group Inc. 10,381
Next Page